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The DF-4 is a new defibrillator lead technology. We present two cases of non-physiological
transient ventricular over-sensing in patients who underwent implantation of an ICD for
secondary prevention. Case 1 had ventricular over-sensing during pacing threshold eval-
uation post defibrillation testing while Case 2 had the lead integrity alert triggered
immediately post discharge with transient over-sensing. No lead-connector issues were
found. Case 1 was likely due to improper venting of the header and trapped air. Case 2 was
hypothesized to be due to intermittent header pin non-contact secondary to blood in the
header. These cases reveal that DF-4 leads are subject to both reported and potentially
novel causes of transient acute ventricular over-sensing.
Copyright © 2015, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).The DF-4 connector is a novel defibrillator lead connection to
the generator and is becoming an industry standard. No long-
term data exist as to its safety and efficacy. We describe two
cases of non-physiological ventricular over-sensing in the
new DF-4 connector system.Case 1
A 55-year-old male underwent implantation of a secondary
prevention dual chamber Boston Scientific Incepta
implantable cardioverter-defibrillator (ICD). A dual coil DF-4
lead (Endotak Reliance LLHH 64 cm) was positioned at the
right ventricular apex (RVA) with normal intracardiac elec-
trograms (EGM). Parameters were satisfactory (R-wave111; fax: þ61 7 3176 7630
ov.au (P.A. Gould).
eart Rhythm Society.
ythm Society. Production
mons.org/licenses/by-ncsensing of 7.9 mV, impedance of 960 U, threshold of 0.6 V @
0.5 ms, and a high voltage impedance of 39 U) and defibril-
lation threshold testing (DFT) was acceptable. Baseline
sensing was set at 0.5 mV. Subsequent to defibrillation
testing, unusual low amplitude and medium frequency sig-
nals were observed on the ventricular EGM (Fig. 1) and
detected on the marker channel during pacing threshold
testing (Fig. 2) which were clearly not related to T-wave
over-sensing.
Fluoroscopic review of set-screw positioning was unre-
markable andmanipulation of the device did not influence the
signals. No further intervention was performed at that stage
and pacing threshold testing the next day demonstrated no
over sensing recurrence and he proceeded to have an event
free six-week follow-up..
and hosting by Elsevier B.V. This is an open access article under
-nd/4.0/).
Fig. 1 e EGM post DFT revealing low amplitude signals seen on the ventricular channel (circled) but not sensed by the device
(as evidenced by absent sensed ventricular beats e VS, on themarker channel corresponding to the artefacts). EGM channels
for both upper and lower panels: First line ¼ Atrial EGM, Second line ¼ Ventricular EGM, Third line ¼ Shock EGM (distal coil
to can), Fourth line: Atrial and ventricular pace/sense marker channel. AS ¼ Atrial sensed beat, VS ¼ Ventricular sensed
beat.
Fig. 2 e EGM post DFT threshold testing showing ventricular over-sensing of the artefact during pacing threshold testing
(denoted by rectangular box showing that the artefacts are now being sensed by the device as VS, on the marker channel).
EGM channels for both upper and lower panels: First line ¼ Atrial EGM, Second line ¼ Ventricular EGM, Third line ¼ Shock
EGM (distal coil to can), Fourth line ¼ Atrial and ventricular pace/sense marker channel. Fifth line ¼ Pacing output.
AS ¼ Atrial Sensed Beat, VS ¼ Ventricular Sensed Beat, VP ¼ Ventricular Paced Beat.
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A 42-year-old female underwent implantation of a second-
ary prevention dual chamber Medtronic Maximo II DF-4 ICD
with a dual coil (Sprint Quattro Secure 6947M 64 cm) ven-
tricular lead at the RVA. After multiple attempts at posi-
tioning the lead, the best R-wave sensing obtained was only
6.8 mV, while other pacing parameters were satisfactory (V-
lead impedance of 684, V-lead threshold of 0.5 V @ 0.5 ms,
high threshold impedance of 42 U and a DFT test of <25 J). R
wave baseline sensitivity was set at 0.5 mV. At discharge,
a small hematoma was managed conservatively withpressure bandaging. She represented one day after with
lead integrity alerts due to high ventricular impedance
(>3000). Device interrogation revealed ventricular over-
sensing (Fig. 3).
Chest X-ray demonstrated the pin beyond the set-screw
(Fig. 4).
During pocket revision, whilst the lead was still connected,
only tapping the header reproduced similar “noise”, while
traction of the lead and movement of the generator were
unremarkable. A moderate hematoma was evacuated and
lead testing unconnected to the header was also unexcep-
tional. The header contained a significant amount of blood.
Interrogation after the header was cleaned and reconnected
Fig. 3 e EGM during ICD interrogation post high impedance alarm showing intermittent high frequency signals with varying
amplitudes and ventricular over-sensing. EGM channels: First line ¼ Atrial EGM, Second line ¼ Ventricular EGM, Third
line ¼ Atrial and ventricular pace/sense marker channel. AS ¼ Atrial sensed beat, VS¼Ventricular sensed beat,
FS¼ Fibrillation sensed beat, Ab ¼ Atrial beat during blanking period, AR ¼ Atrial refractory sensed event.
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6-week follow-up was normal.Discussion
In this report, we present two unusual cases of intermittent
ventricular over-sensing in the newDF-4 connector system. In
both cases, causes of inappropriate sensing of physiologic
signals such as myopotentials, T waves, P waves, R-wave
double counting, after potentials, and far-field physiologic
signals were not present. Consequently, causes of non-
physiological over-sensing need to be evaluated. These
include electromagnetic interference from an external source,
lead/connector problems (loose set screw, adapter, or header),
and lead failure (insulation defect or conductor coil fracture).Fig. 4 eMagnified chest X-ray image of the device in-situ in
the left pre-pectoral pocket prior to pocket revision
showing complete pin insertion.Both of our cases share several similar characteristics: (1)
the over-sensing occurred acutely post implantation (within
24 h); (2) the over-sensing was intermittent and did not have a
constant relationship to the cardiac cycle; (3) although the
over-sensing could be reproduced with specific maneuvers
(during pacing in Case 1, and onlywith tapping of the header in
Case 2), manipulation of the leads and generator did not
recreate the over-sensing; (4) the over-sensing had resolved
spontaneously (as in the first case) or on reconnection without
replacing the lead or the device (as in the second case); (5) peri-
procedural lead functionwasnormal; (6) therewasno evidence
radiographically to suggest incomplete lead advancement; and
(7) no sources of electromagnetic interference, including
electro-cautery were present. These features seem to make an
obvious lead-connector problem or lead failure unlikely.
Case 1 likely relates to the improper venting of the grommet
seal plug (and similar issues have been previously reported
with IS-1 systems). The seal plug is a polymer plug with a
narrow slit through which the set-screw torque wrench is
inserted through to the grommet. It is designed to allow access
of the wrench to the set-screw and maintain electrical isola-
tion afterwards by preventing body fluids from entering the
header ports once thewrench is removed.Atwrench insertion,
care should be exercised to locate the pre-slit depression of the
seal plug and carefully guide thewrench through the slit to the
set-screw cavity beneath prior to insertion of the lead into the
port. This will open up the seal plug, relieving any potential
pressure build-up within the lead port by providing a pathway
to release trapped fluid or air during lead insertion. If this is not
performed adequately, or if damage occurs during wrench
insertion or faulty from manufacturing, the trapped air (an
electrical insulator) is able to intermittently escape the header,
altering the baseline contact between the normally separated
extracellular fluid and the conductive elements of the
connector causing transient alterations in the voltage input to
the sense amplifier and resulting in “make-break” potentials.
Once the air has fully escaped, there is equilibration of charge
and the over-sensing ceases [1,2].
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engaged prior to lead insertion into the header considering
that gross review of the seal plugs revealed no clear abnor-
mality, and that the signals resolved spontaneously without
the need for generator replacement. The resulting signals,
however, had occurred post DFT testing only [1,2] and over-
sensed during ventricular threshold testing. During defibril-
lation testing chestwallmovement or transient pressurization
from the shock or both, could also have encouraged air-bubble
release [2]. Curiously, the over-sensing had only occurred
during instances when the signals were located just after the
post-pacing blanking period. This may relate to the ICD's
automatically adjusted sensitivity programing. After a paced
ventricular event, all ICDs have the ability to adjust sensitivity
dynamically, beginning from the end of the blanking period,
with the threshold starting at a more sensitive setting.
Our second case, however, raises some novel risks that
may need to be considered with this new generation lead-
connector system. This technology encompasses a com-
bined single port cavity with four contacts of which both high-
and low-voltage applications can be placed within the same
cavity which result in compromised space for insulation and
sealing. Furthermore, contact pressure of the seals and the
pins has to be limited to allow for easy insertion and retraction
of the lead connector. This was achieved by alterations in the
design with integration of the sealed rings within the header
itself (instead of being mounted on the lead) as well as the
development of a unique torque wrench activated levering of
the spring loaded pin contacts [3]. Consequently, DF-4 lead
plugs have to go through four seals with three intermediate
spring contacts while its predecessor, the IS-1 lead connec-
tors, have only one seal on the lead and no spring contacts.
This raises potential issues with sealing failures, which may
cause sensing problems or short circuits.
In Case 2, we hypothesize that blood from the hematoma
may have entered the header via a “grommet punch-out” post
wrench removal (which has been previously reported in
Medtronic DF-1 header connections) or forced into the header
through imperfections of the more complex-designed sealed
rings. The nature of seal plugs though may also provide an
alternate explanation. The silicone rubber used for seal plugs
has a “shape memory”. However, during the re-bonding pro-
cess after wrench removal, they may require a short time to
reseal. Until the seal fully closes, it is possible that the header
may be infiltrated by body fluid. This could have been further
compounded by issues with trapped air that were mentioned
earlier in the manuscript. The extracellular fluid in the header
from Case 2 could then have contributed to minute misalign-
ment of the newly developed spring contacts with the lead,
causing the observed increase in impedance and the inter-
mittent non-physiological ventricular over-sensing. This hy-
pothesis was supported by the resolution of the “noise” when
the system was cleaned and simply reconnected without
changing the device, as well as by the lack of any macroscopic
appearance of lead-connecter or set-screw issues.
To the best of our knowledge, cases of non-physiological
ventricular over-sensing have rarely been reported involving
the new DF-4 system. The advantages of this standard over its
predecessor mainly relate to procedural ease and patient
comfort by reducing the riskof lead-to-portmismatch, reducedrisk of lead-to-can abrasion (because of fewer connectors), a
reduced size of device header and subsequently a much less
bulkypocket.However, thesedesign changesmayhave several
potential risks aswehavehighlightedaswell as some logistical
drawbacks. The compact system is also likely to be less flexible
like in instances where there may be a need for the addition of
pace/sense leads (in cases of sensing problems) or additional
shock leads (e.g. subcutaneousarrays). Currently, a single post-
market study has demonstrated that the DF-4 lead has per-
formedwell at a 36-month follow-up period in 1701 caseswith
complication rates reported to be at a low 0.015 per patient-
year of follow-up with no adverse set-screw events [4]. How-
ever, it is important to note that there have been two previous
adverse event reports found in the Manufacturer and User
Facility Device Experience (MAUDE) database run by the FDA.
They both relate to noise and inappropriate therapy, and were
put down to lead-connection issues but with no conclusive
evidence of set-screw problems [3].
The DF-4 connector system is becoming industry standard
but our current cases underscore that potential problems
regarding lead header attachment, that were seen with the
older connector systems, continue to remain an identifiable
cause for over-sensing. Furthermore, they highlight certain
concerns over novel lead-connector problems that need to be
adequately tackled to reduce improper delivery of device
therapies and increased patient morbidity. Unanticipated
problems with DF-4 ICD leads are likely to accumulate. In a
comprehensive review on this topic in Europace in April 2012,
Sticherling and Burri express concern that the complex design
of the header/lead interface could lead to sensing or electrical
isolation problems [3]. Correct torque wrench technique con-
tinues to be an important aspect in device implantation, but
it is clear that further research and development is required
to address any other potential newer causes of non-
physiological over-sensing whose magnitude of risk may not
yet be fully evident at the present time.Disclosures and financial sources
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